Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Translational Oncology|June 18, 2014
Activation of oncogenic pathways in idiopathic pulmonary fibrosisGiulia M Stella, Simona Inghilleri, Ymera Pignochino, et al.
Respiratory Medicine Case Reports|January 9, 2016
Unexpected responses to EGFR inhibition in NSCLCGiulia M Stella, Claudio Valizia, Michele Zorzetto, et al.
Transplant Immunology|September 19, 2019
Peripheral CD19+CD24<sup>high</sup>CD38<sup>high</sup> B-regulatory cells in lung transplant recipientsDavide Piloni, Monica Morosini, Sara Magni, et al.
Plos One|August 27, 2016
Identification of miRNAs Potentially Involved in Bronchiolitis Obliterans Syndrome: A Computational StudyStefano Di Carlo, Elena Rossi, Gianfranco Politano, et al.
Multidisciplinary Respiratory Medicine|August 21, 2018
5-hydroxymethylcytosine but not MTAP methylation status can stratify malignant pleural mesothelioma based on the lineage of originMatteo Bosio, Elena Salvaterra, Francesca Datturi, et al.
Nanomedicine (London, England)|February 25, 2014
Antibody-engineered nanoparticles selectively inhibit mesenchymal cells isolated from patients with chronic lung allograft dysfunctionEmanuela Cova, Miriam Colombo, Simona Inghilleri, et al.
Journal of Cancer Research and Clinical Oncology|May 7, 2013
EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cellsGiulia M Stella, Roberta Scabini, Simona Inghilleri, et al.
International Journal of Nanomedicine|February 19, 2019
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro studyEmanuela Cova, Laura Pandolfi, Miriam Colombo, et al.
Cells|April 3, 2021
miRNAs Potentially Involved in Post Lung Transplant-Obliterative Bronchiolitis: The Role of miR-21-5pSara Bozzini, Laura Pandolfi, Elena Rossi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 15, 2013
Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesotheliomaDaniel E Schwed Lustgarten, Charuhas Deshpande, Charu Aggarwal, et al.
Pageof 3